Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-15-000116
Filing Date
2015-01-09
Accepted
2015-01-09 17:41:54
Documents
1
Period of Report
2015-01-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1554
  Complete submission text file 0001493152-15-000116.txt   3088
Mailing Address 2811 WESTWOOD PL WAYZATA MN 55391
Business Address
LINDSTROM RICHARD L MD (Reporting) CIK: 0001242177 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35814 | Film No.: 15520076

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations